Melanocytic Lesions: Difference between revisions
No edit summary |
No edit summary |
||
| Line 323: | Line 323: | ||
'''Table 2. Rates in percentage of | '''Table 2. Rates in percentage of copy number Aabnormalities commonly tested on FISH panels across different melanoma subtypes.*''' | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
| Line 389: | Line 389: | ||
|0 (83) | |0 (83) | ||
|} | |} | ||
'''Table 3. Rates of abnormalities detected by FISH panels for each melanoma subtype and 95% confidence intervals for the given rates.''' | <nowiki>*</nowiki>The symbol “-” designates data not available; Values in red represent rates calculated from <25 reported cases; The number of reported cases appears in parentheses (). | ||
'''Table 3. Rates of abnormalities detected by FISH panels for each melanoma subtype and 95% confidence intervals for the given rates.*''' | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
| Line 434: | Line 437: | ||
|169 | |169 | ||
|} | |} | ||
'''Table 4. The percentage of melanomas with greater than 3 CNAs reported by CMA for each melanoma subtype and the 95% confidence lower bound for the proportion in the given number of reported cases.''' | <nowiki>*</nowiki>The number of cases on which the rates are based is given. | ||
'''Table 4. The percentage of melanomas with greater than 3 copy number abnormalities (CNAs) reported by chromosomal microarray (CMA) for each melanoma subtype and the 95% confidence lower bound for the proportion in the given number of reported cases.''' | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||